Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Woulgan in Diabetic Foot Ulcer Compared With a Commercial Hydrogel

NCT02631512 is registered in ClinicalTrials.gov with Biotec Pharmacon ASA as lead sponsor.

NCT NCT02631512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02631512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Woulgan in Diabetic Foot Ulcer Compared With a Commercial Hydrogel
Lead sponsor
Biotec Pharmacon ASA
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2015
Completion date
April 30, 2019
Enrollment
62 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcers